NATCO Pharma is a research-focused pharmaceutical company established in 1981. It was founded with a simple but ambitious mission to provide and increase accessibility of specialty medicines in India. We pioneered a lot of first-time generic medicine launches in India thereby improving accessibility and affordability to the therapy. NATCO has an integrated business strategy spanning development, manufacturing and marketing of Finished Dosage Formulations (FDFs), Active Pharmaceutical Ingredients (APIs) and Agrochemicals. Backed by 4+ decades of industry experience, we have evolved into a global enterprise with presence in more than 50 countries through 13 subsidiaries, step-down subsidiaries and an Associate. NATCO also acquired 49% stake at present in the Adcock Ingram Holding Proprietary Limited. Second largest pharma company in terms of private market share in South Africa. NATCO Pharma has evolved from a single-unit operation and a small team into an international pharmaceutical Company with a team of 5200+ globally as on FY26 and 10 manufacturing facilities at present. Company reported total income of Rs 43,759 million in the financial year 2025-26. The Company established NATCO Crop Health Sciences business backed by its techno legal strength in 2019.